Sebastian Meyer
Chief Operating Officer
Management
Numab
Switzerland
Biography
Sebastian joined Numab in 2012 to head the engineering and process development group. In 2017, he was promoted to Chief Operating Officer of Numab Innovation. Prior to joining Numab, Sebastian headed the downstream processing and analytics unit of ESBATech, focusing on process development and characterization of novel scFv drug candidates in Phase I/II of clinical development, including RTH258 (brolucizumab). Prior to that, Sebastian was a bioprocess development group leader at Cytos Biotechnology. During his post-graduate studies, Sebastian investigated the structure and function of chloride channels and transporters. Sebastian graduated with a degree in Biochemistry from the University of Hamburg and obtained his PhD from the University of Zurich.
Research Interest
Molecular Biology and Neurosciences, Biochemistry, Business management
